Papers
1
Total Citations
5
H-Index
1
About
Driven by a commitment to advancing minimally invasive bariatric surgery, Dr. Xu Shu-mei has established herself as a leading voice in the comparative effectiveness of robotic and laparoscopic techniques. Her primary research focuses on optimizing surgical outcomes for patients with morbid obesity, with a particular emphasis on Roux-en-Y gastric bypass procedures. Dr. Xu’s most impactful contribution is a landmark systematic review and meta-analysis (2024), which rigorously compared primary robotic versus conventional laparoscopic gastric bypass. This work, already garnering 5 citations shortly after publication, provides crucial evidence for surgeons debating the adoption of robotic platforms, highlighting key differences in operative time, complications, and recovery. By synthesizing data from multiple studies, Dr. Xu has helped clarify the role of robotics in bariatric surgery, offering a balanced assessment of its benefits and limitations. Her meticulous approach to evidence synthesis makes her a trusted resource for clinicians seeking to refine their surgical practice. As her citation count grows, Dr. Xu’s work continues to shape the conversation around technology-driven improvements in patient care, solidifying her reputation as a thoughtful contributor to the field of metabolic and bariatric surgery.
Research Focus
Key Achievements
Top Papers
- 1